{"id":29298,"date":"2025-03-20T14:58:39","date_gmt":"2025-03-20T12:58:39","guid":{"rendered":"https:\/\/vaccinatiepunt.nl\/?p=29298"},"modified":"2026-04-08T11:34:39","modified_gmt":"2026-04-08T09:34:39","slug":"hpv-ve-servi%cc%87ks-kanseri%cc%87nde-onemli%cc%87-geli%cc%87smeler","status":"publish","type":"post","link":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/","title":{"rendered":"HPV ve rahim a\u011fz\u0131 kanserinde \u00f6nemli geli\u015fmeler"},"content":{"rendered":"
<\/span>\"\"
\n

HPV ve rahim a\u011fz\u0131 kanserinde \u00f6nemli geli\u015fmeler<\/p>\n<\/div><\/div>\n\n\n\n

<\/p>\n\n\n\n

Son \u00e7al\u0131\u015fmalar ve uluslararas\u0131 giri\u015fimler, HPV a\u015f\u0131lamas\u0131n\u0131n ve fark\u0131ndal\u0131\u011f\u0131n\u0131n serviks kanserinin \u00f6nlenmesindeki hayati \u00f6nemini yeniden vurgulamaktad\u0131r. A\u015fa\u011f\u0131da baz\u0131 \u00f6nemli geli\u015fmelere genel bir bak\u0131\u015f sunulmaktad\u0131r.<\/p>\n\n\n\n

Serviks kanseri olan gen\u00e7 kad\u0131nlar aras\u0131nda d\u00fc\u015f\u00fck a\u015f\u0131lama kapsam\u0131<\/strong><\/h3>\n\n\n\n

Yak\u0131n zamanda Hollanda'da yap\u0131lan bir \u00e7al\u0131\u015fmada, rahim a\u011fz\u0131 kanseri olan 30 ya\u015f alt\u0131 kad\u0131nlar\u0131n sadece 15%'sinin insan papilloma vir\u00fcs\u00fcne (HPV) kar\u015f\u0131 a\u015f\u0131lanm\u0131\u015f oldu\u011fu bulunmu\u015ftur. Buna kar\u015f\u0131l\u0131k, ayn\u0131 ya\u015f grubundaki genel n\u00fcfusta en az 55% a\u015f\u0131 yapt\u0131rm\u0131\u015ft\u0131r. Bu fark, rahim a\u011fz\u0131 kanserinin \u00f6nlenmesinde a\u015f\u0131laman\u0131n \u00f6nleyici potansiyelini vurgulamaktad\u0131r.

Jinekolog-onkolog Luc van Lonkhuijzen (Amsterdam UMC) \"Son y\u0131llarda rahim a\u011fz\u0131 kanseri olan ve a\u015f\u0131lanmam\u0131\u015f \u00e7ok say\u0131da gen\u00e7 kad\u0131n g\u00f6rd\u00fck\" diyor.

Bu durum, a\u015f\u0131lama kapsam\u0131n\u0131n art\u0131r\u0131lmas\u0131 ve HPV a\u015f\u0131lamas\u0131 konusunda fark\u0131ndal\u0131k yarat\u0131lmas\u0131n\u0131n aciliyetini vurgulamaktad\u0131r.<\/p>\n\n\n\n

Uluslararas\u0131 HPV Fark\u0131ndal\u0131k G\u00fcn\u00fc 2025<\/strong><\/h4>\n\n\n\n

Eri\u015fim adresi 4 Mart 2025<\/strong> buldum Uluslararas\u0131 HPV Fark\u0131ndal\u0131k G\u00fcn\u00fc<\/strong> hakk\u0131nda bilgiyi art\u0131rmaya adanm\u0131\u015f bir g\u00fcn ger\u00e7ekle\u015fecek. HPV ve \u00f6nleyici tedbirler<\/strong> Vir\u00fcs\u00fcn neden olabilece\u011fi \u00e7e\u015fitli kanser t\u00fcrlerine kar\u015f\u0131. D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc de dahil olmak \u00fczere Uluslararas\u0131 Papillomavir\u00fcs Derne\u011fi (IPVS)<\/strong>\u00f6nemini te\u015fvik etmek i\u00e7in etkinlikler ve kampanyalar d\u00fczenlemektedir. a\u015f\u0131lama ve erken te\u015fhis<\/strong> vurgulay\u0131n.<\/p>\n\n\n\n

Erkekler ve HPV: Az bildirilen bir sa\u011fl\u0131k riski<\/strong><\/h4>\n\n\n\n

HPV'nin \u00f6nlenmesi, rahim a\u011fz\u0131 kanseri ile ba\u011flant\u0131s\u0131 nedeniyle uzun s\u00fcredir esas olarak kad\u0131nlara odaklanm\u0131\u015ft\u0131r. Ancak son bulgular HPV'nin erkekler i\u00e7in de \u00f6nemli bir sa\u011fl\u0131k riski olu\u015fturdu\u011funu g\u00f6stermektedir. Vir\u00fcs\u00fcn potansiyel olarak a\u011f\u0131z, bo\u011faz, penis ve an\u00fcs kanserlerine yol a\u00e7mas\u0131, a\u015f\u0131lama stratejilerini geni\u015fletmeyi ve \u00f6nleme kampanyalar\u0131na her iki cinsiyeti de dahil etmeyi daha \u00f6nce g\u00f6r\u00fclmemi\u015f derecede \u00f6nemli hale getirmektedir. Bu, HPV'nin etkisiyle d\u00fcnya \u00e7ap\u0131nda daha etkin bir \u015fekilde m\u00fccadele edilmesine yard\u0131mc\u0131 olacakt\u0131r.<\/p>\n\n\n\n

Son zamanlarda ortaya \u00e7\u0131kan g\u00f6r\u00fc\u015fler ve giri\u015fimler, hem kad\u0131nlarda hem de erkeklerde HPV ile ili\u015fkili kanserlerin \u00f6nlenmesinde HPV a\u015f\u0131lamas\u0131 ve taramas\u0131n\u0131n temel rol\u00fcn\u00fc vurgulamaktad\u0131r. A\u015f\u0131lama oranlar\u0131n\u0131n art\u0131r\u0131lmas\u0131, fark\u0131ndal\u0131\u011f\u0131n art\u0131r\u0131lmas\u0131 ve eri\u015filebilir tarama y\u00f6ntemlerinin uygulanmas\u0131, insan papilloma vir\u00fcs\u00fcn\u00fcn etkisini azaltmak ve d\u00fcnya \u00e7ap\u0131nda sa\u011fl\u0131\u011f\u0131 iyile\u015ftirmek i\u00e7in ba\u015flang\u0131\u00e7 ad\u0131mlar\u0131d\u0131r. A\u015f\u0131 hakk\u0131nda daha fazla bilgi almak ve nereden a\u015f\u0131 yapt\u0131rabilece\u011finizi \u00f6\u011frenmek i\u00e7in A\u015f\u0131 Noktas\u0131'n\u0131 ziyaret edin.<\/p>\n\n\n\n

Kaynaklar:
<\/strong>NOS<\/a>
IARC<\/a>
Ulusal A\u015f\u0131lama Program\u0131<\/a>
IKNL<\/a><\/p>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

Recente studies en internationale initiatieven benadrukken opnieuw het cruciale belang van HPV-vaccinatie en bewustwording in de preventie van baarmoederhalskanker. Hieronder een overzicht van enkele belangrijke ontwikkelingen. Lage vaccinatiegraad onder jonge vrouwen met baarmoederhalskanker Een recente Nederlandse studie heeft aangetoond dat slechts 15% van de vrouwen onder de 30 jaar met baarmoederhalskanker gevaccineerd was tegen het […]<\/p>\n","protected":false},"author":6,"featured_media":29300,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[106],"tags":[],"class_list":["post-29298","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nieuws-nl"],"yoast_head":"\nBelangrijke ontwikkelingen in HPV en baarmoederhalskanker - Vaccinatiepunt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vaccinatiepunt.nl\/tr\/hpv-ve-servi\u0307ks-kanseri\u0307nde-onemli\u0307-geli\u0307smeler\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belangrijke ontwikkelingen in HPV en baarmoederhalskanker - Vaccinatiepunt\" \/>\n<meta property=\"og:description\" content=\"Recente studies en internationale initiatieven benadrukken opnieuw het cruciale belang van HPV-vaccinatie en bewustwording in de preventie van baarmoederhalskanker. Hieronder een overzicht van enkele belangrijke ontwikkelingen. Lage vaccinatiegraad onder jonge vrouwen met baarmoederhalskanker Een recente Nederlandse studie heeft aangetoond dat slechts 15% van de vrouwen onder de 30 jaar met baarmoederhalskanker gevaccineerd was tegen het […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vaccinatiepunt.nl\/tr\/hpv-ve-servi\u0307ks-kanseri\u0307nde-onemli\u0307-geli\u0307smeler\/\" \/>\n<meta property=\"og:site_name\" content=\"Vaccinatiepunt\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-20T12:58:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-08T09:34:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1708\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hille\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"hille\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 dakika\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HPV ve rahim a\u011fz\u0131 kanserinde \u00f6nemli geli\u015fmeler - A\u015f\u0131 Noktas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vaccinatiepunt.nl\/tr\/hpv-ve-servi\u0307ks-kanseri\u0307nde-onemli\u0307-geli\u0307smeler\/","og_locale":"tr_TR","og_type":"article","og_title":"Belangrijke ontwikkelingen in HPV en baarmoederhalskanker - Vaccinatiepunt","og_description":"Recente studies en internationale initiatieven benadrukken opnieuw het cruciale belang van HPV-vaccinatie en bewustwording in de preventie van baarmoederhalskanker. Hieronder een overzicht van enkele belangrijke ontwikkelingen. Lage vaccinatiegraad onder jonge vrouwen met baarmoederhalskanker Een recente Nederlandse studie heeft aangetoond dat slechts 15% van de vrouwen onder de 30 jaar met baarmoederhalskanker gevaccineerd was tegen het […]","og_url":"https:\/\/vaccinatiepunt.nl\/tr\/hpv-ve-servi\u0307ks-kanseri\u0307nde-onemli\u0307-geli\u0307smeler\/","og_site_name":"Vaccinatiepunt","article_published_time":"2025-03-20T12:58:39+00:00","article_modified_time":"2026-04-08T09:34:39+00:00","og_image":[{"width":2560,"height":1708,"url":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg","type":"image\/jpeg"}],"author":"hille","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"hille","Tahmini okuma s\u00fcresi":"3 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#article","isPartOf":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/"},"author":{"name":"hille","@id":"https:\/\/vaccinatiepunt.nl\/tr\/#\/schema\/person\/c73a733dc1580043f173e5c926b746ab"},"headline":"Belangrijke ontwikkelingen in HPV en baarmoederhalskanker","datePublished":"2025-03-20T12:58:39+00:00","dateModified":"2026-04-08T09:34:39+00:00","mainEntityOfPage":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/"},"wordCount":345,"publisher":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/#organization"},"image":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#primaryimage"},"thumbnailUrl":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg","articleSection":["Nieuws"],"inLanguage":"tr"},{"@type":"WebPage","@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/","url":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/","name":"HPV ve rahim a\u011fz\u0131 kanserinde \u00f6nemli geli\u015fmeler - A\u015f\u0131 Noktas\u0131","isPartOf":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#primaryimage"},"image":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#primaryimage"},"thumbnailUrl":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg","datePublished":"2025-03-20T12:58:39+00:00","dateModified":"2026-04-08T09:34:39+00:00","breadcrumb":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#primaryimage","url":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg","contentUrl":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/03\/pexels-klaus-nielsen-6303792-edited-scaled.jpg","width":2560,"height":1708},{"@type":"BreadcrumbList","@id":"https:\/\/vaccinatiepunt.nl\/tr\/belangrijke-ontwikkelingen-in-hpv-en-baarmoederhalskanker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vaccinatiepunt.nl\/"},{"@type":"ListItem","position":2,"name":"Belangrijke ontwikkelingen in HPV en baarmoederhalskanker"}]},{"@type":"WebSite","@id":"https:\/\/vaccinatiepunt.nl\/tr\/#website","url":"https:\/\/vaccinatiepunt.nl\/tr\/","name":"A\u015f\u0131lama noktas\u0131","description":"","publisher":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vaccinatiepunt.nl\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/vaccinatiepunt.nl\/tr\/#organization","name":"A\u015f\u0131lama noktas\u0131","url":"https:\/\/vaccinatiepunt.nl\/tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/vaccinatiepunt.nl\/tr\/#\/schema\/logo\/image\/","url":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/12\/Zonder-titel-Instagram-bericht.png","contentUrl":"https:\/\/vaccinatiepunt.nl\/wp-content\/uploads\/2025\/12\/Zonder-titel-Instagram-bericht.png","width":1080,"height":1080,"caption":"Vaccinatiepunt"},"image":{"@id":"https:\/\/vaccinatiepunt.nl\/tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/vaccinatiepunt.nl\/tr\/#\/schema\/person\/c73a733dc1580043f173e5c926b746ab","name":"hille","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/501c3eeff19967ac18f56fb76ef727925b7e76c6da7f534801f670a6118eb835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/501c3eeff19967ac18f56fb76ef727925b7e76c6da7f534801f670a6118eb835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/501c3eeff19967ac18f56fb76ef727925b7e76c6da7f534801f670a6118eb835?s=96&d=mm&r=g","caption":"hille"}}]}},"_links":{"self":[{"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/posts\/29298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/comments?post=29298"}],"version-history":[{"count":0,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/posts\/29298\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/media\/29300"}],"wp:attachment":[{"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/media?parent=29298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/categories?post=29298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vaccinatiepunt.nl\/tr\/wp-json\/wp\/v2\/tags?post=29298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}